StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) stock

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30152% above fair value
$56.95+1.58 (+2.85%)

Close on Nov 18, 2026Market cap $3.40BP/E –Yield –

Axogen net income

Net income is the profit left for shareholders after every expense, interest and tax.

Axogen's net income for the twelve months ending Sep 30, 2026 was -$31.92M. For fiscal 2025 it was -$15.70M. The highest annual figure on record is -$5.42M in fiscal 2010.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.70M–
FY2024Dec 31, 2024-$9.96M–
FY2023Dec 31, 2023-$21.72M–
FY2022Dec 31, 2022-$28.95M–
FY2021Dec 31, 2021-$26.99M–
FY2020Dec 31, 2020-$23.79M–
FY2019Dec 31, 2019-$29.14M–
FY2018Dec 31, 2018-$22.40M–
FY2017Dec 31, 2017-$10.45M–
FY2016Dec 31, 2016-$14.41M–
FY2015Dec 31, 2015-$13.36M–
FY2014Dec 31, 2014-$17.71M–
FY2013Dec 31, 2013-$14.56M–
FY2012Dec 31, 2012-$9.42M–
FY2011Dec 31, 2011-$9.22M–
FY2010Dec 31, 2010-$5.42M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.33M+229.7%
Q2 FY2026Jun 30, 2026-$1.52M-361.8%
Q1 FY2026Mar 31, 2026-$19.58M–
Q4 FY2025Dec 31, 2025-$13.16M-3023.6%
Q3 FY2025Sep 30, 2025$708.00K–
Q2 FY2025Jun 30, 2025$579.00K–
Q1 FY2025Mar 31, 2025-$3.83M–
Q4 FY2024Dec 31, 2024$450.00K–
Q3 FY2024Sep 30, 2024-$1.86M–
Q2 FY2024Jun 30, 2024-$1.92M–
Q1 FY2024Mar 31, 2024-$6.64M–
Q4 FY2023Dec 31, 2023-$3.89M–
Q3 FY2023Sep 30, 2023-$4.09M–
Q2 FY2023Jun 30, 2023-$6.66M–
Q1 FY2023Mar 31, 2023-$7.07M–
Q4 FY2022Dec 31, 2022-$5.42M–
Q3 FY2022Sep 30, 2022-$4.32M–
Q2 FY2022Jun 30, 2022-$7.74M–
Q1 FY2022Mar 31, 2022-$11.48M–
Q4 FY2021Dec 31, 2021-$5.29M–
Q3 FY2021Sep 30, 2021-$7.14M–
Q2 FY2021Jun 30, 2021-$7.90M–
Q1 FY2021Mar 31, 2021-$6.66M–
Q4 FY2020Dec 31, 2020-$6.01M–
Q3 FY2020Sep 30, 2020-$1.48M–
Q2 FY2020Jun 30, 2020-$8.11M–
Q1 FY2020Mar 31, 2020-$8.19M–
Q4 FY2019Dec 31, 2019-$7.04M–
Q3 FY2019Sep 30, 2019-$5.57M–
Q2 FY2019Jun 30, 2019-$7.02M–
Q1 FY2019Mar 31, 2019-$9.50M–
Q4 FY2018Dec 31, 2018-$5.22M–
Q3 FY2018Sep 30, 2018-$4.10M–
Q2 FY2018Jun 30, 2018-$7.43M–
Q1 FY2018Mar 31, 2018-$5.64M–
Q4 FY2017Dec 31, 2017-$2.50M–
Q3 FY2017Sep 30, 2017-$2.12M–
Q2 FY2017Jun 30, 2017-$2.06M–
Q1 FY2017Mar 31, 2017-$3.76M–
Q4 FY2016Dec 31, 2016-$5.63M–

More Axogen figures

See a number that looks wrong?